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The First Case of Adult-Onset Periodic Fever, Aphthous 
Stomatitis, Pharyngitis, and Adenitis Syndrome with 
Splenomegaly in Iran 
 
Abstract 
Background: Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome 
(PFAPA) is an auto-immune based disease known as a syndrome for pediatrics which 
typically occurs in children ≤ 5 years of age, but in 2008, for the first time, one adult case 
of this disease was reported. 
Case Presentation: Our case, a 19 year-old young man who is the first adult-onset PFAPA 
patient in Iran and was accompanied by splenomegaly. Since March 2017, the patient 
suffered from periodic febrile attacks (39-40 °C). During these fever attacks, the patient 
had many aphthous ulcers in his mouth, swollen glands in his neck and sore in the back of 
the throat. The patient was admitted to a hospital in Tehran during a severe fever attack 
due to weakness, lethargy, high-temperature and slight abdominal pain in the left upper 
quadrant (LUQ) area. Abdominal sonography was done and spleen size was larger than 
normal and was determined to be 32×140 mm (splenomegaly). All data were collected 
from a reliable governmental laboratory in Tehran. 
Conclusion: Following the rejection of the causes of other diseases, according to the 
patient's symptoms, the diagnosis of adult-onset PFAPA was given to the patient and the 
patient was cured with one dose of long-acting Betamethasone ampoule 1ml intravenous at 
the onset of fever attacks. The disease has remitted after injection of this medicine at the 
onset of each attack rapidly after about 2-3 hours. Also, Montelukast has been given to the 
patient and we saw his febrile attack intervals increased. 
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Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA) is 
an auto-immune based disease described as sudden attacks of high fever on a regular basis 
(periodic fever) (1) with sores in mouth (aphthous stomatitis) (2), sore throat (pharyngitis) 
and swollen glands (adenitis). The cause of PFAPA has not been known yet. Its reasons 
have not been understood yet; the body’s inflammation system becomes active, leading to 
the symptoms of PFAPA. Although the cause of this syndrome has been difficult to 
identify, the effects on lifestyle can be notable. Previous studies have shown antibiotics do 
not alter symptoms from this condition, but corticosteroid therapy has shown to reduce 
fever quickly (3). The frequency of PFAPA has not been known and may be the most 
common recurrent fever (auto inflammatory) that does not come from an infection. Both 
males and females and all ethnic groups can develop PFAPA. In the past, for a long time 
this disease known as a syndrome for pediatrics typically occurs in children 5 years of age 
and under, but in 2008 for the first time one adult case of this disease was reported (4).  
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Our case is the first adult onset PFAPA patient in Iran 
accompanied by splenomegaly 
 
 
Case presentation 
The patient is a 19 year-old boy with normal body mass 
index (BMI) and normal blood pressure. He was born and 
has lived in Tehran city (Iran) and for first the time since 
March 2017, he suffered from periodic febrile attacks (39-40 
°C).  During these fever attacks, the patient had many 
aphthous ulcers in his mouth, swollen glands in his neck and 
sore in the back of the throat. The fever periods in this 
patient lasted about 7 days, and after the disease went down, 
the next attack occurred about 45 days later, the patient also 
had a feeling of weakness, severe fatigue in the limbs, and a 
slight abdominal pain in LUQ area during the time of the 
attacks. 
For first time in July 2017, the patient was admitted to 
the hospital during a severe fever attack due to weakness, 
lethargy, and high temperature. Doctors noticed the high 
fever (39.8 °C), severe aphthous month ulcers inflammation 
in throat, and swollen lymph nodes on the neck during 
physical examination. Furthermore, after examining the 
patient's abdomen, doctors found splenomegaly in this 
patient. 
After these examinations, during the hospitalization in 
July 2017, doctors requested some laboratory tests to 
determine the cause of the disease. These tests include: urine 
culture (UC), blood culture (BC), stool exam (SE), stool 
culture (SC), human immunodeficiency virus antibody (HIV 
Ab), hepatitis B antigen (HBS Ag), hepatitis C virus 
antibody (HCV Ab), rheumatoid factor (RF), erythrocyte 
sedimentation rate (ESR), peripheral blood smear (PBS), 
malaria, borrelia, fluorescent antinuclear antibody (FANA), 
anti-cyclic citrullinated peptide (anti CCP), which the results 
of all these tests were negative except ESR (numerical value 
of ESR was 31), and the patient was given an abdominal 
ultrasound examination to determine the size of the spleen. It 
was larger than normal, and was determined to be 32 × 140 
mm (splenomegaly) (figure 1 A, B). 
Following the rejection of the causes of other diseases, 
according to the patient's symptoms, the diagnosis of adult 
onset PFAPA was given to the patient and the patient was 
cured by slow intravenous injection of one dose of long-
acting betamethasone ampoule (1 ml) at the onset of the 
fever attacks. Disease remission after injection of this 
medicine at the onset of each attack rapidly after about 2-3 
hours, and all symptoms included oral ulcers, inflammation 
of the throat and swollen neck lymph nodes on the neck were 
completely resolved. In October 2017, the patient was 
treated with tab Montelukast sodium 10 mg once a day. 
After taking this medicine, the febrile attack periods 
occurred once every 55-65 days, and the duration of 
remission increased. The laboratory tests were taken in July 
2017 during the patients fever attack when patient was 
admitted in the hospital. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. a) The abdomen sonography shows increased 
echo in spleen parenchyma. b) The abdomen sonography 
shows the spleen size enlargement. 
 
 
Discussion 
In this study, we report the first adult-onset case of 
PFAPA in Iran that had signs and symptoms since was 19 
years old. This case is the first patient with adult-onset 
PFAPA in Iran. There are a few studies on adult-onset 
PFAPA in the world. The adult-onset of PFAPA is a new 
discovery, since it has been specified in 2008 (4, 5). This is 
the reason that this disease used to be thought that its onset 
only belongs to children before 5 year-old (6-8) or about 18 
months (9-11). In the past, the prevalence of this syndrome is 
unknown so far (5). Our case has been presented, with all the 
signs and symptoms similar to what Marshall et al. has 
reported on PFAPA syndrome in 1987 (12). Our patient had 
periodic fever, aphthous stomatitis, pharyngitis, and cervical 
adenitis (6, 13).  
There are some minor symptoms like vomiting, 
abdominal pain, rash, nausea, headache, weakness, 
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arthralgia, and etc. that were seen in the adult-onset of 
PFAPA syndrome (8) but in our case, he had only fatigue, 
malaise, headache, and abdominal pain from minor 
symptoms during the attacks. We cannot see any signs and 
symptoms between each attack though. The patients with 
PFAPA syndrome usually show febrile attacks occurring 
every 2 to 12 weeks (mean=4.5 weeks) but in our patient, it 
recurred every 6 to 7 weeks (8, 9). This fever reached the 
temperatures of 40-41 °C, while our case reached 39-40 °C. 
Also, our case had a significant splenomegaly (32×140 mm). 
Whereas, in previous studies, adult-onset PFAPA syndrome 
has not been stated while we ruled out other causes and 
diseases related to it. We should consider that many studies 
need confirmation of these 2 mentioned symptoms etc. In 
this study, the patient has been ruled out of his other all 
differential diagnoses (DDxs) including familial 
mediterranean fever (FMF), behcet’s disease, acquired 
immune deficiency syndrome (HIV/AIDS), cyclic 
neutropenia, tumor necrosis factor receptors-associated 
periodic syndrome (TRAPS), hyperglobulinemia D 
syndrome (HIDS), juvenile rheumatoid arthritis, autosomal 
dominant hereditary periodic fever syndrome (HPF), and 
cryopyrin-associated periodic syndromes (CAPS) (12, 14). 
They have ruled up 2 adult-onset PFAPA syndrome case 
report studies in Japan recently (5, 15).  
There is no study on adult onset patient of PFAPA 
syndrome in Iran though. In our patient, bacterial, fungal, 
and viral tests were done and all of them were negative. (5, 
17) Our case has no leucocytosis and neutropenia. To 
distinguish adult-onset PFAPA from other DDxs, 5 points 
should be attended; 1. present illness 2. signs & symptoms 3. 
family history 4. genetic tests and 5. response to 
corticosteroids. From these 5 key points, in our study we 
only have not done genetic tests. With regard to genetic 
factors, autosomal recessive and dominant inheritance 
patterns were seen in FMF, TRAPS & CAPS patients, 
respectively. Whereas, there is no specific inheritance pattern 
found for PFAPA syndrome yet. Likewise, mutation in 
MEFV, TNFR1, and NLRP1 can be seen in FMF, TRAPS, 
and CAPS. If genetic tests cannot be done like our case, we 
can give the patient a single dose of prednisolone (60 mg) 
(4) and fast response (a few hours) is visible whereas rapid 
response to corticosteroids in other auto inflammatory 
diseases is seen very rarely. 
Nowadays, the treatment of PFAPA is divided into 2 
methods; 1. medical (nonsurgical) 2. surgical. In medical 
treatment, patients should take oral corticosteroids, 
cimetidine, and Montelukast. In surgical methods, we can 
often suggest tonsillectomy (18). 
There are no definite treatments for PFAPA, because its 
pathogeneses have not been discovered clearly so far. But 
some previous studies have suggested empirical treatments 
such as prednisolone (1-2 mg/kg), betamethasone (0.1-0.2 
mg/kg), or dexamethasone (3-6 mg/daily). These types of 
corticosteroids have been suggested to be taken at the 
duration of febrile attack and attack episodes. They are so 
useful for getting rid attack of signs and symptoms, it cannot 
prevent future relapse though (4, 8, 19). 
Some previous studies have mentioned that the main 
theory and causes of PFAPA disease can be explained by   
T-helpr1 related immune cytokines, overexpression of 
Interleukin-1, and interferon-affected genes (5, 20, 21). 
There are so many studies about the consumption and 
benefits of cimetidine which proposed a 400-800 mg/day 
dosage based on previous studies (5, 16) although we have 
not given our patient at all. A study reported that giving 
Montelukast to PFAPA patients increased the febrile attack 
intervals (21). Our patient was prescribed this medicine and 
had maximum response. 
The strong points of this study are: 1. reporting a rare 
disease in the world (PFAPA) that had a splenomegaly, 2. 
Diagnosis and timely treatment of the disease, 3. Increase the 
effect of treatment and interval between periods of 
recurrence of disease with the use of Montelukast; and the 
weak point is the side effects of Montelukast, which include 
an increased risk of respiratory infections and 
gastrointestinal disturbances, of which, given the PFAPA's 
irreversible side effects appear to be beneficial and the side 
effects of these drugs can be overlooked. 
About the limitations, the cooperation of the patient and 
his family was difficult for us since they have hardly been 
responding to our questions and providing us medical 
records and lab tests. 
In Conclusion, We have identified the first case of PFAPA 
syndrome in Iran that has been adult onset. Adult-onset 
PFAPA syndrome is a rare type. For the diagnosis of adult-
onset PFAPA, the physicians should rule out other DDxs that 
we did in our study. Our case had splenomegaly in addition 
to Marshall et al.’s symptoms. We ruled out all DDxs with 
splenomegaly. Our case had all major Marshall et al’s. 
symptoms. Furthermore, he had fatigue, malaise, headache, 
and abdominal pain in minor criteria during the attack 
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episodes. We gave Montelukast to our patient-case and we 
saw a good effect. With this prescription his remission 
duration has increased to 55-65 days. Nonetheless, other 
studies are needed to be investigated in terms of its 
effectiveness.  
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